Further research demonstrated that LPA augmented calcium influx prompted by α, β-meATP via P2X3R in primary DRG neurons from rats experiencing bone cancer pain, which could be blocked by the LPAR1 antagonist VPC32183 and the RhoA inhibitor C3 exoenzyme. Here, LPAR1 is linked to bone cancer.